FSSAI issues notice to Dr Reddy's, Nestle JV over Celevida GLP+
In short
India's food regulator, FSSAI, has sent a notice to Dr Reddy's and Nestle India's joint venture over claims made for the Celevida GLP+ supplement. The report says the claims were seen as misleading.
This matters because it may affect how the product is sold and promoted. It is still not known what action, if any, the regulator will take next.
What the reporting says
India's food regulator, FSSAI, issued a notice to Dr Reddy's and Nestle India's joint venture over misleading claims tied to its Celevida GLP+ supplement, according to a publisher summary. The report does not state the exact claims or the regulator's next step. The notice could affect the product and the companies' marketing, but the available reporting does not say whether penalties or changes have been ordered.
Why it matters
FSSAI has issued a notice to Dr Reddy's and Nestle India's joint venture over alleged misleading claims for Celevida GLP+. The source does not specify the wording of the claims or whether any enforcement action follows. The notice puts the product and the two companies under regulatory scrutiny, and could influence consumer perception, but the immediate commercial impact is not stated in the available reporting.